APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Grade CBD Oil

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pharmaceutical Grade CBD Oil Market Analysis and Forecast 2026-2032

Report ID 174024850231 December 2025203 pages

Choose your research edition.

Industry ResearchPharmaceutical Grade CBD Oil Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Grade CBD Oil Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Grade CBD Oil Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Grade CBD Oil Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Grade CBD Oil Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Pharmaceutical Grade CBD Oil market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pharmaceutical Grade CBD Oil is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pharmaceutical Grade CBD Oil is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pharmaceutical Grade CBD Oil is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pharmaceutical Grade CBD Oil is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Pharmaceutical Grade CBD Oil include Absolute Terps, Aphria, Cannavest, Canopy Growth Corporation, CBD American Shaman, Charlotte's Web, Emblem Cannabis Oils, ENDOCA and Folium Biosciences, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pharmaceutical Grade CBD Oil, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pharmaceutical Grade CBD Oil, also provides the sales of main regions and countries. Of the upcoming market potential for Pharmaceutical Grade CBD Oil, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pharmaceutical Grade CBD Oil sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pharmaceutical Grade CBD Oil market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Pharmaceutical Grade CBD Oil sales, projected growth trends, production technology, application and end-user industry.

Pharmaceutical Grade CBD Oil Segment by Company

Absolute Terps

Aphria

Cannavest

Canopy Growth Corporation

CBD American Shaman

Charlotte's Web

Emblem Cannabis Oils

ENDOCA

Folium Biosciences

GL Brands, Inc.

Green Road

HempLife Today

K.I.N.D. Concentrates

Kazmira

Medical Marijuana, Inc.

NuLeaf Naturals

PHARM-CBD, LLC

The Lab

Whistler

Pharmaceutical Grade CBD Oil Segment by Type

Full Spectrum CBD Oil

Broad Spectrum CBD Oil

Pharmaceutical Grade CBD Oil Segment by Application

Anxiety

Diabetes

Fibromyalgia

Others

Pharmaceutical Grade CBD Oil Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Grade CBD Oil market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Grade CBD Oil and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Grade CBD Oil.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Pharmaceutical Grade CBD Oil in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Pharmaceutical Grade CBD Oil manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical Grade CBD Oil sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pharmaceutical Grade CBD Oil Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Full Spectrum CBD Oil Major Manufacturers Table 3. Broad Spectrum CBD Oil Major Manufacturers Table 4. Global Pharmaceutical Grade CBD Oil Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Anxiety Major Manufacturers Table 6. Diabetes Major Manufacturers Table 7. Fibromyalgia Major Manufacturers Table 8. Others Major Manufacturers Table 9. Pharmaceutical Grade CBD Oil Industry Trends Table 10. Pharmaceutical Grade CBD Oil Industry Drivers Table 11. Pharmaceutical Grade CBD Oil Industry Opportunities and Challenges Table 12. Pharmaceutical Grade CBD Oil Industry Restraints Table 13. Global Pharmaceutical Grade CBD Oil Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Pharmaceutical Grade CBD Oil Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Pharmaceutical Grade CBD Oil Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Pharmaceutical Grade CBD Oil Revenue Market Share by Region (2021-2026) Table 17. Global Pharmaceutical Grade CBD Oil Revenue Market Share by Region (2027-2032) Table 18. Global Pharmaceutical Grade CBD Oil Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Tons) Table 19. Global Pharmaceutical Grade CBD Oil Sales by Region (2021-2026) & (Tons) Table 20. Global Pharmaceutical Grade CBD Oil Sales by Region (2027-2032) & (Tons) Table 21. Global Pharmaceutical Grade CBD Oil Sales Market Share by Region (2021-2026) Table 22. Global Pharmaceutical Grade CBD Oil Sales Market Share by Region (2027-2032) Table 23. Global Pharmaceutical Grade CBD Oil Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Pharmaceutical Grade CBD Oil Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Pharmaceutical Grade CBD Oil Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Pharmaceutical Grade CBD Oil Sales Market Share by Manufacturers (2021-2026) Table 27. Global Pharmaceutical Grade CBD Oil Sales Price (US$/Kg) of Manufacturers (2021-2026) Table 28. Global Pharmaceutical Grade CBD Oil Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Pharmaceutical Grade CBD Oil Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Pharmaceutical Grade CBD Oil Manufacturers, Product Type & Application Table 31. Global Pharmaceutical Grade CBD Oil Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Pharmaceutical Grade CBD Oil by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Pharmaceutical Grade CBD Oil Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Pharmaceutical Grade CBD Oil Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Pharmaceutical Grade CBD Oil Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Pharmaceutical Grade CBD Oil Revenue Market Share by Type (2021-2026) Table 38. Global Pharmaceutical Grade CBD Oil Revenue Market Share by Type (2027-2032) Table 39. Global Pharmaceutical Grade CBD Oil Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 40. Global Pharmaceutical Grade CBD Oil Sales by Type (2021-2026) & (Tons) Table 41. Global Pharmaceutical Grade CBD Oil Sales by Type (2027-2032) & (Tons) Table 42. Global Pharmaceutical Grade CBD Oil Sales Market Share by Type (2021-2026) Table 43. Global Pharmaceutical Grade CBD Oil Sales Market Share by Type (2027-2032) Table 44. Global Pharmaceutical Grade CBD Oil Price by Type (2021-2026) & (US$/Kg) Table 45. Global Pharmaceutical Grade CBD Oil Price by Type (2027-2032) & (US$/Kg) Table 46. Global Pharmaceutical Grade CBD Oil Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Pharmaceutical Grade CBD Oil Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Pharmaceutical Grade CBD Oil Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Pharmaceutical Grade CBD Oil Revenue Market Share by Application (2021-2026) Table 50. Global Pharmaceutical Grade CBD Oil Revenue Market Share by Application (2027-2032) Table 51. Global Pharmaceutical Grade CBD Oil Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 52. Global Pharmaceutical Grade CBD Oil Sales by Application (2021-2026) & (Tons) Table 53. Global Pharmaceutical Grade CBD Oil Sales by Application (2027-2032) & (Tons) Table 54. Global Pharmaceutical Grade CBD Oil Sales Market Share by Application (2021-2026) Table 55. Global Pharmaceutical Grade CBD Oil Sales Market Share by Application (2027-2032) Table 56. Global Pharmaceutical Grade CBD Oil Price by Application (2021-2026) & (US$/Kg) Table 57. Global Pharmaceutical Grade CBD Oil Price by Application (2027-2032) & (US$/Kg) Table 58. Absolute Terps Company Information Table 59. Absolute Terps Business Overview Table 60. Absolute Terps Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 61. Absolute Terps Pharmaceutical Grade CBD Oil Product Portfolio Table 62. Absolute Terps Recent Development Table 63. Aphria Company Information Table 64. Aphria Business Overview Table 65. Aphria Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 66. Aphria Pharmaceutical Grade CBD Oil Product Portfolio Table 67. Aphria Recent Development Table 68. Cannavest Company Information Table 69. Cannavest Business Overview Table 70. Cannavest Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 71. Cannavest Pharmaceutical Grade CBD Oil Product Portfolio Table 72. Cannavest Recent Development Table 73. Canopy Growth Corporation Company Information Table 74. Canopy Growth Corporation Business Overview Table 75. Canopy Growth Corporation Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 76. Canopy Growth Corporation Pharmaceutical Grade CBD Oil Product Portfolio Table 77. Canopy Growth Corporation Recent Development Table 78. CBD American Shaman Company Information Table 79. CBD American Shaman Business Overview Table 80. CBD American Shaman Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 81. CBD American Shaman Pharmaceutical Grade CBD Oil Product Portfolio Table 82. CBD American Shaman Recent Development Table 83. Charlotte's Web Company Information Table 84. Charlotte's Web Business Overview Table 85. Charlotte's Web Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 86. Charlotte's Web Pharmaceutical Grade CBD Oil Product Portfolio Table 87. Charlotte's Web Recent Development Table 88. Emblem Cannabis Oils Company Information Table 89. Emblem Cannabis Oils Business Overview Table 90. Emblem Cannabis Oils Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 91. Emblem Cannabis Oils Pharmaceutical Grade CBD Oil Product Portfolio Table 92. Emblem Cannabis Oils Recent Development Table 93. ENDOCA Company Information Table 94. ENDOCA Business Overview Table 95. ENDOCA Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 96. ENDOCA Pharmaceutical Grade CBD Oil Product Portfolio Table 97. ENDOCA Recent Development Table 98. Folium Biosciences Company Information Table 99. Folium Biosciences Business Overview Table 100. Folium Biosciences Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 101. Folium Biosciences Pharmaceutical Grade CBD Oil Product Portfolio Table 102. Folium Biosciences Recent Development Table 103. GL Brands, Inc. Company Information Table 104. GL Brands, Inc. Business Overview Table 105. GL Brands, Inc. Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 106. GL Brands, Inc. Pharmaceutical Grade CBD Oil Product Portfolio Table 107. GL Brands, Inc. Recent Development Table 108. Green Road Company Information Table 109. Green Road Business Overview Table 110. Green Road Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 111. Green Road Pharmaceutical Grade CBD Oil Product Portfolio Table 112. Green Road Recent Development Table 113. HempLife Today Company Information Table 114. HempLife Today Business Overview Table 115. HempLife Today Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 116. HempLife Today Pharmaceutical Grade CBD Oil Product Portfolio Table 117. HempLife Today Recent Development Table 118. K.I.N.D. Concentrates Company Information Table 119. K.I.N.D. Concentrates Business Overview Table 120. K.I.N.D. Concentrates Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 121. K.I.N.D. Concentrates Pharmaceutical Grade CBD Oil Product Portfolio Table 122. K.I.N.D. Concentrates Recent Development Table 123. Kazmira Company Information Table 124. Kazmira Business Overview Table 125. Kazmira Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 126. Kazmira Pharmaceutical Grade CBD Oil Product Portfolio Table 127. Kazmira Recent Development Table 128. Medical Marijuana, Inc. Company Information Table 129. Medical Marijuana, Inc. Business Overview Table 130. Medical Marijuana, Inc. Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 131. Medical Marijuana, Inc. Pharmaceutical Grade CBD Oil Product Portfolio Table 132. Medical Marijuana, Inc. Recent Development Table 133. NuLeaf Naturals Company Information Table 134. NuLeaf Naturals Business Overview Table 135. NuLeaf Naturals Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 136. NuLeaf Naturals Pharmaceutical Grade CBD Oil Product Portfolio Table 137. NuLeaf Naturals Recent Development Table 138. PHARM-CBD, LLC Company Information Table 139. PHARM-CBD, LLC Business Overview Table 140. PHARM-CBD, LLC Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 141. PHARM-CBD, LLC Pharmaceutical Grade CBD Oil Product Portfolio Table 142. PHARM-CBD, LLC Recent Development Table 143. The Lab Company Information Table 144. The Lab Business Overview Table 145. The Lab Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 146. The Lab Pharmaceutical Grade CBD Oil Product Portfolio Table 147. The Lab Recent Development Table 148. Whistler Company Information Table 149. Whistler Business Overview Table 150. Whistler Pharmaceutical Grade CBD Oil Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 151. Whistler Pharmaceutical Grade CBD Oil Product Portfolio Table 152. Whistler Recent Development Table 153. North America Pharmaceutical Grade CBD Oil Revenue by Type (2021-2026) & (US$ Million) Table 154. North America Pharmaceutical Grade CBD Oil Revenue by Type (2027-2032) & (US$ Million) Table 155. North America Pharmaceutical Grade CBD Oil Sales by Type (2021-2026) & (Tons) Table 156. North America Pharmaceutical Grade CBD Oil Sales by Type (2027-2032) & (Tons) Table 157. North America Pharmaceutical Grade CBD Oil Sales Price by Type (2021-2026) & (US$/Kg) Table 158. North America Pharmaceutical Grade CBD Oil Sales Price by Type (2027-2032) & (US$/Kg) Table 159. North America Pharmaceutical Grade CBD Oil Revenue by Application (2021-2026) & (US$ Million) Table 160. North America Pharmaceutical Grade CBD Oil Revenue by Application (2027-2032) & (US$ Million) Table 161. North America Pharmaceutical Grade CBD Oil Sales by Application (2021-2026) & (Tons) Table 162. North America Pharmaceutical Grade CBD Oil Sales by Application (2027-2032) & (Tons) Table 163. North America Pharmaceutical Grade CBD Oil Sales Price by Application (2021-2026) & (US$/Kg) Table 164. North America Pharmaceutical Grade CBD Oil Sales Price by Application (2027-2032) & (US$/Kg) Table 165. North America Pharmaceutical Grade CBD Oil Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 166. North America Pharmaceutical Grade CBD Oil Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 167. North America Pharmaceutical Grade CBD Oil Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 168. North America Pharmaceutical Grade CBD Oil Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 169. North America Pharmaceutical Grade CBD Oil Sales by Country (2021-2026) & (Tons) Table 170. North America Pharmaceutical Grade CBD Oil Sales by Country (2027-2032) & (Tons) Table 171. North America Pharmaceutical Grade CBD Oil Sales Price by Country (2021-2026) & (US$/Kg) Table 172. North America Pharmaceutical Grade CBD Oil Sales Price by Country (2027-2032) & (US$/Kg) Table 173. United States Pharmaceutical Grade CBD Oil Revenue (2021-2032) & (US$ Million) Table 174. Canada Pharmaceutical Grade CBD Oil Revenue (2021-2032) & (US$ Million) Table 175. Europe Pharmaceutical Grade CBD Oil Revenue by Type (2021-2026) & (US$ Million) Table 176. Europe Pharmaceutical Grade CBD Oil Revenue by Type (2027-2032) & (US$ Million) Table 177. Europe Pharmaceutical Grade CBD Oil Sales by Type (2021-2026) & (Tons) Table 178. Europe Pharmaceutical Grade CBD Oil Sales by Type (2027-2032) & (Tons) Table 179. Europe Pharmaceutical Grade CBD Oil Sales Price by Type (2021-2026) & (US$/Kg) Table 180. Europe Pharmaceutical Grade CBD Oil Sales Price by Type (2027-2032) & (US$/Kg) Table 181. Europe Pharmaceutical Grade CBD Oil Revenue by Application (2021-2026) & (US$ Million) Table 182. Europe Pharmaceutical Grade CBD Oil Revenue by Application (2027-2032) & (US$ Million) Table 183. Europe Pharmaceutical Grade CBD Oil Sales by Application (2021-2026) & (Tons) Table 184. Europe Pharmaceutical Grade CBD Oil Sales by Application (2027-2032) & (Tons) Table 185. Europe Pharmaceutical Grade CBD Oil Sales Price by Application (2021-2026) & (US$/Kg) Table 186. Europe Pharmaceutical Grade CBD Oil Sales Price by Application (2027-2032) & (US$/Kg) Table 187. Europe Pharmaceutical Grade CBD Oil Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 188. Europe Pharmaceutical Grade CBD Oil Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 189. Europe Pharmaceutical Grade CBD Oil Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 190. Europe Pharmaceutical Grade CBD Oil Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 191. Europe Pharmaceutical Grade CBD Oil Sales by Country (2021-2026) & (Tons) Table 192. Europe Pharmaceutical Grade CBD Oil Sales by Country (2027-2032) & (Tons) Table 193. Europe Pharmaceutical Grade CBD Oil Sales Price by Country (2021-2026) & (US$/Kg) Table 194. Europe Pharmaceutical Grade CBD Oil Sales Price by Country (2027-2032) & (US$/Kg) Table 195. Germany Pharmaceutical Grade CBD Oil Revenue (2021-2032) & (US$ Million) Table 196. France Pharmaceutical Grade CBD Oil Revenue (2021-2032) & (US$ Million) Table 197. U.K. Pharmaceutical Grade CBD Oil Revenue (2021-2032) & (US$ Million) Table 198. Italy Pharmaceutical Grade CBD Oil Revenue (2021-2032) & (US$ Million) Table 199. Netherlands Pharmaceutical Grade CBD Oil Revenue (2021-2032) & (US$ Million) Table 200. Nordic Countries Pharmaceutical Grade CBD Oil Revenue (2021-2032) & (US$ Million) Table 201. China Pharmaceutical Grade CBD Oil Revenue by Type (2021-2026) & (US$ Million) Table 202. China Pharmaceutical Grade CBD Oil Revenue by Type (2027-2032) & (US$ Million) Table 203. China Pharmaceutical Grade CBD Oil Sales by Type (2021-2026) & (Tons) Table 204. China Pharmaceutical Grade CBD Oil Sales by Type (2027-2032) & (Tons) Table 205. China Pharmaceutical Grade CBD Oil Sales Price by Type (2021-2026) & (US$/Kg) Table 206. China Pharmaceutical Grade CBD Oil Sales Price by Type (2027-2032) & (US$/Kg) Table 207. China Pharmaceutical Grade CBD Oil Revenue by Application (2021-2026) & (US$ Million) Table 208. China Pharmaceutical Grade CBD Oil Revenue by Application (2027-2032) & (US$ Million) Table 209. China Pharmaceutical Grade CBD Oil Sales by Application (2021-2026) & (Tons) Table 210. China Pharmaceutical Grade CBD Oil Sales by Application (2027-2032) & (Tons) Table 211. China Pharmaceutical Grade CBD Oil Sales Price by Application (2021-2026) & (US$/Kg) Table 212. China Pharmaceutical Grade CBD Oil Sales Price by Application (2027-2032) & (US$/Kg) Table 213. Asia Pharmaceutical Grade CBD Oil Revenue by Type (2021-2026) & (US$ Million) Table 214. Asia Pharmaceutical Grade CBD Oil Revenue by Type (2027-2032) & (US$ Million) Table 215. Asia Pharmaceutical Grade CBD Oil Sales by Type (2021-2026) & (Tons) Table 216. Asia Pharmaceutical Grade CBD Oil Sales by Type (2027-2032) & (Tons) Table 217. Asia Pharmaceutical Grade CBD Oil Sales Price by Type (2021-2026) & (US$/Kg) Table 218. Asia Pharmaceutical Grade CBD Oil Sales Price by Type (2027-2032) & (US$/Kg) Table 219. Asia Pharmaceutical Grade CBD Oil Revenue by Application (2021-2026) & (US$ Million) Table 220. Asia Pharmaceutical Grade CBD Oil Revenue by Application (2027-2032) & (US$ Million) Table 221. Asia Pharmaceutical Grade CBD Oil Sales by Application (2021-2026) & (Tons) Table 222. Asia Pharmaceutical Grade CBD Oil Sales by Application (2027-2032) & (Tons) Table 223. Asia Pharmaceutical Grade CBD Oil Sales Price by Application (2021-2026) & (US$/Kg) Table 224. Asia Pharmaceutical Grade CBD Oil Sales Price by Application (2027-2032) & (US$/Kg) Table 225. Asia Pharmaceutical Grade CBD Oil Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 226. Asia Pharmaceutical Grade CBD Oil Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 227. Asia Pharmaceutical Grade CBD Oil Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 228. Asia Pharmaceutical Grade CBD Oil Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 229. Asia Pharmaceutical Grade CBD Oil Sales by Country (2021-2026) & (Tons) Table 230. Asia Pharmaceutical Grade CBD Oil Sales by Country (2027-2032) & (Tons) Table 231. Asia Pharmaceutical Grade CBD Oil Sales Price by Country (2021-2026) & (US$/Kg) Table 232. Asia Pharmaceutical Grade CBD Oil Sales Price by Country (2027-2032) & (US$/Kg) Table 233. Japan Pharmaceutical Grade CBD Oil Revenue (2021-2032) & (US$ Million) Table 234. South Korea Pharmaceutical Grade CBD Oil Revenue (2021-2032) & (US$ Million) Table 235. India Pharmaceutical Grade CBD Oil Revenue (2021-2032) & (US$ Million) Table 236. Australia Pharmaceutical Grade CBD Oil Revenue (2021-2032) & (US$ Million) Table 237. China Taiwan Pharmaceutical Grade CBD Oil Revenue (2021-2032) & (US$ Million) Table 238. Southeast Asia Pharmaceutical Grade CBD Oil Revenue (2021-2032) & (US$ Million) Table 239. SAMEA Pharmaceutical Grade CBD Oil Revenue by Type (2021-2026) & (US$ Million) Table 240. SAMEA Pharmaceutical Grade CBD Oil Revenue by Type (2027-2032) & (US$ Million) Table 241. SAMEA Pharmaceutical Grade CBD Oil Sales by Type (2021-2026) & (Tons) Table 242. SAMEA Pharmaceutical Grade CBD Oil Sales by Type (2027-2032) & (Tons) Table 243. SAMEA Pharmaceutical Grade CBD Oil Sales Price by Type (2021-2026) & (US$/Kg) Table 244. SAMEA Pharmaceutical Grade CBD Oil Sales Price by Type (2027-2032) & (US$/Kg) Table 245. SAMEA Pharmaceutical Grade CBD Oil Revenue by Application (2021-2026) & (US$ Million) Table 246. SAMEA Pharmaceutical Grade CBD Oil Revenue by Application (2027-2032) & (US$ Million) Table 247. SAMEA Pharmaceutical Grade CBD Oil Sales by Application (2021-2026) & (Tons) Table 248. SAMEA Pharmaceutical Grade CBD Oil Sales by Application (2027-2032) & (Tons) Table 249. SAMEA Pharmaceutical Grade CBD Oil Sales Price by Application (2021-2026) & (US$/Kg) Table 250. SAMEA Pharmaceutical Grade CBD Oil Sales Price by Application (2027-2032) & (US$/Kg) Table 251. SAMEA Pharmaceutical Grade CBD Oil Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 252. SAMEA Pharmaceutical Grade CBD Oil Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 253. SAMEA Pharmaceutical Grade CBD Oil Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 254. SAMEA Pharmaceutical Grade CBD Oil Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 255. SAMEA Pharmaceutical Grade CBD Oil Sales by Country (2021-2026) & (Tons) Table 256. SAMEA Pharmaceutical Grade CBD Oil Sales by Country (2027-2032) & (Tons) Table 257. SAMEA Pharmaceutical Grade CBD Oil Sales Price by Country (2021-2026) & (US$/Kg) Table 258. SAMEA Pharmaceutical Grade CBD Oil Sales Price by Country (2027-2032) & (US$/Kg) Table 259. Brazil Pharmaceutical Grade CBD Oil Revenue (2021-2032) & (US$ Million) Table 260. Argentina Pharmaceutical Grade CBD Oil Revenue (2021-2032) & (US$ Million) Table 261. Chile Pharmaceutical Grade CBD Oil Revenue (2021-2032) & (US$ Million) Table 262. Colombia Pharmaceutical Grade CBD Oil Revenue (2021-2032) & (US$ Million) Table 263. Peru Pharmaceutical Grade CBD Oil Revenue (2021-2032) & (US$ Million) Table 264. Saudi Arabia Pharmaceutical Grade CBD Oil Revenue (2021-2032) & (US$ Million) Table 265. Israel Pharmaceutical Grade CBD Oil Revenue (2021-2032) & (US$ Million) Table 266. UAE Pharmaceutical Grade CBD Oil Revenue (2021-2032) & (US$ Million) Table 267. Turkey Pharmaceutical Grade CBD Oil Revenue (2021-2032) & (US$ Million) Table 268. Iran Pharmaceutical Grade CBD Oil Revenue (2021-2032) & (US$ Million) Table 269. Egypt Pharmaceutical Grade CBD Oil Revenue (2021-2032) & (US$ Million) Table 270. Key Raw Materials Table 271. Raw Materials Key Suppliers Table 272. Pharmaceutical Grade CBD Oil Distributors List Table 273. Pharmaceutical Grade CBD Oil Customers List Table 274. Research Programs/Design for This Report Table 275. Authors List of This Report Table 276. Secondary Sources Table 277. Primary Sources List of Figures Figure 1. Pharmaceutical Grade CBD Oil Image Figure 2. Global Pharmaceutical Grade CBD Oil Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical Grade CBD Oil Market Size Share 2021 VS 2025 VS 2032 Figure 4. Full Spectrum CBD Oil Image Figure 5. Broad Spectrum CBD Oil Image Figure 6. Global Pharmaceutical Grade CBD Oil Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Pharmaceutical Grade CBD Oil Market Size Share 2021 VS 2025 VS 2032 Figure 8. Anxiety Image Figure 9. Diabetes Image Figure 10. Fibromyalgia Image Figure 11. Others Image Figure 12. Global Pharmaceutical Grade CBD Oil Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Pharmaceutical Grade CBD Oil Revenue (2021-2032) & (US$ Million) Figure 14. Global Pharmaceutical Grade CBD Oil Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Pharmaceutical Grade CBD Oil Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Pharmaceutical Grade CBD Oil Revenue Market Share by Region (2021-2032) Figure 17. Global Pharmaceutical Grade CBD Oil Sales (2021-2032) & (Tons) Figure 18. Global Pharmaceutical Grade CBD Oil Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 19. Global Pharmaceutical Grade CBD Oil Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Pharmaceutical Grade CBD Oil Sales YoY (2021-2032) & (Tons) Figure 21. Europe Pharmaceutical Grade CBD Oil Sales YoY (2021-2032) & (Tons) Figure 22. China Pharmaceutical Grade CBD Oil Sales YoY (2021-2032) & (Tons) Figure 23. Asia (Excluding China) Pharmaceutical Grade CBD Oil Sales YoY (2021-2032) & (Tons) Figure 24. South America, Middle East and Africa Pharmaceutical Grade CBD Oil Sales YoY (2021-2032) & (Tons) Figure 25. Global Pharmaceutical Grade CBD Oil Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Pharmaceutical Grade CBD Oil Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Pharmaceutical Grade CBD Oil Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Pharmaceutical Grade CBD Oil Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Pharmaceutical Grade CBD Oil Revenue Market Share by Type (2021-2032) Figure 31. Global Pharmaceutical Grade CBD Oil Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 32. Global Pharmaceutical Grade CBD Oil Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Pharmaceutical Grade CBD Oil Sales Market Share by Type (2021-2032) Figure 34. Global Pharmaceutical Grade CBD Oil Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Pharmaceutical Grade CBD Oil Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Pharmaceutical Grade CBD Oil Revenue Market Share by Application (2021-2032) Figure 37. Global Pharmaceutical Grade CBD Oil Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 38. Global Pharmaceutical Grade CBD Oil Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Pharmaceutical Grade CBD Oil Sales Market Share by Application (2021-2032) Figure 40. North America Pharmaceutical Grade CBD Oil Revenue Share by Type (2021-2032) Figure 41. North America Pharmaceutical Grade CBD Oil Sales Share by Type (2021-2032) Figure 42. North America Pharmaceutical Grade CBD Oil Revenue Share by Application (2021-2032) Figure 43. North America Pharmaceutical Grade CBD Oil Sales Share by Application (2021-2032) Figure 44. North America Pharmaceutical Grade CBD Oil Revenue Share by Country (2021-2032) Figure 45. North America Pharmaceutical Grade CBD Oil Sales Share by Country (2021-2032) Figure 46. Europe Pharmaceutical Grade CBD Oil Revenue Share by Type (2021-2032) Figure 47. Europe Pharmaceutical Grade CBD Oil Sales Share by Type (2021-2032) Figure 48. Europe Pharmaceutical Grade CBD Oil Revenue Share by Application (2021-2032) Figure 49. Europe Pharmaceutical Grade CBD Oil Sales Share by Application (2021-2032) Figure 50. Europe Pharmaceutical Grade CBD Oil Revenue Share by Country (2021-2032) Figure 51. Europe Pharmaceutical Grade CBD Oil Sales Share by Country (2021-2032) Figure 52. China Pharmaceutical Grade CBD Oil Revenue Share by Type (2021-2032) Figure 53. China Pharmaceutical Grade CBD Oil Sales Share by Type (2021-2032) Figure 54. China Pharmaceutical Grade CBD Oil Revenue Share by Application (2021-2032) Figure 55. China Pharmaceutical Grade CBD Oil Sales Share by Application (2021-2032) Figure 56. Asia Pharmaceutical Grade CBD Oil Revenue Share by Type (2021-2032) Figure 57. Asia Pharmaceutical Grade CBD Oil Sales Share by Type (2021-2032) Figure 58. Asia Pharmaceutical Grade CBD Oil Revenue Share by Application (2021-2032) Figure 59. Asia Pharmaceutical Grade CBD Oil Sales Share by Application (2021-2032) Figure 60. Asia Pharmaceutical Grade CBD Oil Revenue Share by Country (2021-2032) Figure 61. Asia Pharmaceutical Grade CBD Oil Sales Share by Country (2021-2032) Figure 62. SAMEA Pharmaceutical Grade CBD Oil Revenue Share by Type (2021-2032) Figure 63. SAMEA Pharmaceutical Grade CBD Oil Sales Share by Type (2021-2032) Figure 64. SAMEA Pharmaceutical Grade CBD Oil Revenue Share by Application (2021-2032) Figure 65. SAMEA Pharmaceutical Grade CBD Oil Sales Share by Application (2021-2032) Figure 66. SAMEA Pharmaceutical Grade CBD Oil Revenue Share by Country (2021-2032) Figure 67. SAMEA Pharmaceutical Grade CBD Oil Sales Share by Country (2021-2032) Figure 68. Pharmaceutical Grade CBD Oil Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Pharmaceutical Grade CBD Oil Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Full Spectrum CBD Oil
  • Broad Spectrum CBD Oil
Applications
  • Anxiety
  • Diabetes
  • Fibromyalgia
  • Others
Companies covered
  • Absolute Terps
  • Aphria
  • Cannavest
  • Canopy Growth Corporation
  • CBD American Shaman
  • Charlotte's Web
  • Emblem Cannabis Oils
  • ENDOCA
  • Folium Biosciences
  • GL Brands, Inc.
  • Green Road
  • HempLife Today
  • K.I.N.D. Concentrates
  • Kazmira
  • Medical Marijuana, Inc.
  • NuLeaf Naturals
  • PHARM-CBD, LLC
  • The Lab
  • Whistler

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pharmaceutical Grade CBD Oil Market by Type
  3. 1.2.1 Global Pharmaceutical Grade CBD Oil Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Full Spectrum CBD Oil
  5. 1.2.3 Broad Spectrum CBD Oil
  6. 1.3 Pharmaceutical Grade CBD Oil Market by Application
  7. 1.3.1 Global Pharmaceutical Grade CBD Oil Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Anxiety
  9. 1.3.3 Diabetes
  10. 1.3.4 Fibromyalgia
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Pharmaceutical Grade CBD Oil Market Dynamics
  1. 2.1 Pharmaceutical Grade CBD Oil Industry Trends
  2. 2.2 Pharmaceutical Grade CBD Oil Industry Drivers
  3. 2.3 Pharmaceutical Grade CBD Oil Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Grade CBD Oil Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Pharmaceutical Grade CBD Oil Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Pharmaceutical Grade CBD Oil Revenue by Region
  3. 3.2.1 Global Pharmaceutical Grade CBD Oil Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pharmaceutical Grade CBD Oil Revenue by Region (2021-2026)
  5. 3.2.3 Global Pharmaceutical Grade CBD Oil Revenue by Region (2027-2032)
  6. 3.2.4 Global Pharmaceutical Grade CBD Oil Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Pharmaceutical Grade CBD Oil Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Pharmaceutical Grade CBD Oil Sales by Region
  9. 3.4.1 Global Pharmaceutical Grade CBD Oil Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Pharmaceutical Grade CBD Oil Sales by Region (2021-2026)
  11. 3.4.3 Global Pharmaceutical Grade CBD Oil Sales by Region (2027-2032)
  12. 3.4.4 Global Pharmaceutical Grade CBD Oil Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Pharmaceutical Grade CBD Oil Revenue by Manufacturers
  2. 4.1.1 Global Pharmaceutical Grade CBD Oil Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Pharmaceutical Grade CBD Oil Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Pharmaceutical Grade CBD Oil Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pharmaceutical Grade CBD Oil Sales by Manufacturers
  6. 4.2.1 Global Pharmaceutical Grade CBD Oil Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Pharmaceutical Grade CBD Oil Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Pharmaceutical Grade CBD Oil Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Pharmaceutical Grade CBD Oil Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Pharmaceutical Grade CBD Oil Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Pharmaceutical Grade CBD Oil Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Pharmaceutical Grade CBD Oil Manufacturers, Product Type & Application
  13. 4.7 Global Pharmaceutical Grade CBD Oil Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Pharmaceutical Grade CBD Oil Market CR5 and HHI
  16. 4.8.2 2025 Pharmaceutical Grade CBD Oil Tier 1, Tier 2, and Tier 3
5 Pharmaceutical Grade CBD Oil Market by Type
  1. 5.1 Global Pharmaceutical Grade CBD Oil Revenue by Type
  2. 5.1.1 Global Pharmaceutical Grade CBD Oil Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Pharmaceutical Grade CBD Oil Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Pharmaceutical Grade CBD Oil Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Pharmaceutical Grade CBD Oil Sales by Type
  6. 5.2.1 Global Pharmaceutical Grade CBD Oil Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pharmaceutical Grade CBD Oil Sales by Type (2021-2032) & (Tons)
  8. 5.2.3 Global Pharmaceutical Grade CBD Oil Sales Market Share by Type (2021-2032)
  9. 5.3 Global Pharmaceutical Grade CBD Oil Price by Type
6 Pharmaceutical Grade CBD Oil Market by Application
  1. 6.1 Global Pharmaceutical Grade CBD Oil Revenue by Application
  2. 6.1.1 Global Pharmaceutical Grade CBD Oil Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Pharmaceutical Grade CBD Oil Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Pharmaceutical Grade CBD Oil Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Pharmaceutical Grade CBD Oil Sales by Application
  6. 6.2.1 Global Pharmaceutical Grade CBD Oil Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Pharmaceutical Grade CBD Oil Sales by Application (2021-2032) & (Tons)
  8. 6.2.3 Global Pharmaceutical Grade CBD Oil Sales Market Share by Application (2021-2032)
  9. 6.3 Global Pharmaceutical Grade CBD Oil Price by Application
7 Company Profiles
  1. 7.1 Absolute Terps
  2. 7.1.1 Absolute Terps Company Information
  3. 7.1.2 Absolute Terps Business Overview
  4. 7.1.3 Absolute Terps Pharmaceutical Grade CBD Oil Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Absolute Terps Pharmaceutical Grade CBD Oil Product Portfolio
  6. 7.1.5 Absolute Terps Recent Developments
  7. 7.2 Aphria
  8. 7.2.1 Aphria Company Information
  9. 7.2.2 Aphria Business Overview
  10. 7.2.3 Aphria Pharmaceutical Grade CBD Oil Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Aphria Pharmaceutical Grade CBD Oil Product Portfolio
  12. 7.2.5 Aphria Recent Developments
  13. 7.3 Cannavest
  14. 7.3.1 Cannavest Company Information
  15. 7.3.2 Cannavest Business Overview
  16. 7.3.3 Cannavest Pharmaceutical Grade CBD Oil Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Cannavest Pharmaceutical Grade CBD Oil Product Portfolio
  18. 7.3.5 Cannavest Recent Developments
  19. 7.4 Canopy Growth Corporation
  20. 7.4.1 Canopy Growth Corporation Company Information
  21. 7.4.2 Canopy Growth Corporation Business Overview
  22. 7.4.3 Canopy Growth Corporation Pharmaceutical Grade CBD Oil Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Canopy Growth Corporation Pharmaceutical Grade CBD Oil Product Portfolio
  24. 7.4.5 Canopy Growth Corporation Recent Developments
  25. 7.5 CBD American Shaman
  26. 7.5.1 CBD American Shaman Company Information
  27. 7.5.2 CBD American Shaman Business Overview
  28. 7.5.3 CBD American Shaman Pharmaceutical Grade CBD Oil Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 CBD American Shaman Pharmaceutical Grade CBD Oil Product Portfolio
  30. 7.5.5 CBD American Shaman Recent Developments
  31. 7.6 Charlotte's Web
  32. 7.6.1 Charlotte's Web Company Information
  33. 7.6.2 Charlotte's Web Business Overview
  34. 7.6.3 Charlotte's Web Pharmaceutical Grade CBD Oil Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Charlotte's Web Pharmaceutical Grade CBD Oil Product Portfolio
  36. 7.6.5 Charlotte's Web Recent Developments
  37. 7.7 Emblem Cannabis Oils
  38. 7.7.1 Emblem Cannabis Oils Company Information
  39. 7.7.2 Emblem Cannabis Oils Business Overview
  40. 7.7.3 Emblem Cannabis Oils Pharmaceutical Grade CBD Oil Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Emblem Cannabis Oils Pharmaceutical Grade CBD Oil Product Portfolio
  42. 7.7.5 Emblem Cannabis Oils Recent Developments
  43. 7.8 ENDOCA
  44. 7.8.1 ENDOCA Company Information
  45. 7.8.2 ENDOCA Business Overview
  46. 7.8.3 ENDOCA Pharmaceutical Grade CBD Oil Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 ENDOCA Pharmaceutical Grade CBD Oil Product Portfolio
  48. 7.8.5 ENDOCA Recent Developments
  49. 7.9 Folium Biosciences
  50. 7.9.1 Folium Biosciences Company Information
  51. 7.9.2 Folium Biosciences Business Overview
  52. 7.9.3 Folium Biosciences Pharmaceutical Grade CBD Oil Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Folium Biosciences Pharmaceutical Grade CBD Oil Product Portfolio
  54. 7.9.5 Folium Biosciences Recent Developments
  55. 7.10 GL Brands, Inc.
  56. 7.10.1 GL Brands, Inc. Company Information
  57. 7.10.2 GL Brands, Inc. Business Overview
  58. 7.10.3 GL Brands, Inc. Pharmaceutical Grade CBD Oil Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 GL Brands, Inc. Pharmaceutical Grade CBD Oil Product Portfolio
  60. 7.10.5 GL Brands, Inc. Recent Developments
  61. 7.11 Green Road
  62. 7.11.1 Green Road Company Information
  63. 7.11.2 Green Road Business Overview
  64. 7.11.3 Green Road Pharmaceutical Grade CBD Oil Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Green Road Pharmaceutical Grade CBD Oil Product Portfolio
  66. 7.11.5 Green Road Recent Developments
  67. 7.12 HempLife Today
  68. 7.12.1 HempLife Today Company Information
  69. 7.12.2 HempLife Today Business Overview
  70. 7.12.3 HempLife Today Pharmaceutical Grade CBD Oil Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 HempLife Today Pharmaceutical Grade CBD Oil Product Portfolio
  72. 7.12.5 HempLife Today Recent Developments
  73. 7.13 K.I.N.D. Concentrates
  74. 7.13.1 K.I.N.D. Concentrates Company Information
  75. 7.13.2 K.I.N.D. Concentrates Business Overview
  76. 7.13.3 K.I.N.D. Concentrates Pharmaceutical Grade CBD Oil Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 K.I.N.D. Concentrates Pharmaceutical Grade CBD Oil Product Portfolio
  78. 7.13.5 K.I.N.D. Concentrates Recent Developments
  79. 7.14 Kazmira
  80. 7.14.1 Kazmira Company Information
  81. 7.14.2 Kazmira Business Overview
  82. 7.14.3 Kazmira Pharmaceutical Grade CBD Oil Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Kazmira Pharmaceutical Grade CBD Oil Product Portfolio
  84. 7.14.5 Kazmira Recent Developments
  85. 7.15 Medical Marijuana, Inc.
  86. 7.15.1 Medical Marijuana, Inc. Company Information
  87. 7.15.2 Medical Marijuana, Inc. Business Overview
  88. 7.15.3 Medical Marijuana, Inc. Pharmaceutical Grade CBD Oil Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Medical Marijuana, Inc. Pharmaceutical Grade CBD Oil Product Portfolio
  90. 7.15.5 Medical Marijuana, Inc. Recent Developments
  91. 7.16 NuLeaf Naturals
  92. 7.16.1 NuLeaf Naturals Company Information
  93. 7.16.2 NuLeaf Naturals Business Overview
  94. 7.16.3 NuLeaf Naturals Pharmaceutical Grade CBD Oil Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 NuLeaf Naturals Pharmaceutical Grade CBD Oil Product Portfolio
  96. 7.16.5 NuLeaf Naturals Recent Developments
  97. 7.17 PHARM-CBD, LLC
  98. 7.17.1 PHARM-CBD, LLC Company Information
  99. 7.17.2 PHARM-CBD, LLC Business Overview
  100. 7.17.3 PHARM-CBD, LLC Pharmaceutical Grade CBD Oil Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 PHARM-CBD, LLC Pharmaceutical Grade CBD Oil Product Portfolio
  102. 7.17.5 PHARM-CBD, LLC Recent Developments
  103. 7.18 The Lab
  104. 7.18.1 The Lab Company Information
  105. 7.18.2 The Lab Business Overview
  106. 7.18.3 The Lab Pharmaceutical Grade CBD Oil Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 The Lab Pharmaceutical Grade CBD Oil Product Portfolio
  108. 7.18.5 The Lab Recent Developments
  109. 7.19 Whistler
  110. 7.19.1 Whistler Company Information
  111. 7.19.2 Whistler Business Overview
  112. 7.19.3 Whistler Pharmaceutical Grade CBD Oil Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Whistler Pharmaceutical Grade CBD Oil Product Portfolio
  114. 7.19.5 Whistler Recent Developments
8 North America
  1. 8.1 North America Pharmaceutical Grade CBD Oil Market Size by Type
  2. 8.1.1 North America Pharmaceutical Grade CBD Oil Revenue by Type (2021-2032)
  3. 8.1.2 North America Pharmaceutical Grade CBD Oil Sales by Type (2021-2032)
  4. 8.1.3 North America Pharmaceutical Grade CBD Oil Price by Type (2021-2032)
  5. 8.2 North America Pharmaceutical Grade CBD Oil Market Size by Application
  6. 8.2.1 North America Pharmaceutical Grade CBD Oil Revenue by Application (2021-2032)
  7. 8.2.2 North America Pharmaceutical Grade CBD Oil Sales by Application (2021-2032)
  8. 8.2.3 North America Pharmaceutical Grade CBD Oil Price by Application (2021-2032)
  9. 8.3 North America Pharmaceutical Grade CBD Oil Market Size by Country
  10. 8.3.1 North America Pharmaceutical Grade CBD Oil Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Pharmaceutical Grade CBD Oil Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Pharmaceutical Grade CBD Oil Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Pharmaceutical Grade CBD Oil Market Size by Type
  2. 9.1.1 Europe Pharmaceutical Grade CBD Oil Revenue by Type (2021-2032)
  3. 9.1.2 Europe Pharmaceutical Grade CBD Oil Sales by Type (2021-2032)
  4. 9.1.3 Europe Pharmaceutical Grade CBD Oil Price by Type (2021-2032)
  5. 9.2 Europe Pharmaceutical Grade CBD Oil Market Size by Application
  6. 9.2.1 Europe Pharmaceutical Grade CBD Oil Revenue by Application (2021-2032)
  7. 9.2.2 Europe Pharmaceutical Grade CBD Oil Sales by Application (2021-2032)
  8. 9.2.3 Europe Pharmaceutical Grade CBD Oil Price by Application (2021-2032)
  9. 9.3 Europe Pharmaceutical Grade CBD Oil Market Size by Country
  10. 9.3.1 Europe Pharmaceutical Grade CBD Oil Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Pharmaceutical Grade CBD Oil Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Pharmaceutical Grade CBD Oil Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Pharmaceutical Grade CBD Oil Market Size by Type
  2. 10.1.1 China Pharmaceutical Grade CBD Oil Revenue by Type (2021-2032)
  3. 10.1.2 China Pharmaceutical Grade CBD Oil Sales by Type (2021-2032)
  4. 10.1.3 China Pharmaceutical Grade CBD Oil Price by Type (2021-2032)
  5. 10.2 China Pharmaceutical Grade CBD Oil Market Size by Application
  6. 10.2.1 China Pharmaceutical Grade CBD Oil Revenue by Application (2021-2032)
  7. 10.2.2 China Pharmaceutical Grade CBD Oil Sales by Application (2021-2032)
  8. 10.2.3 China Pharmaceutical Grade CBD Oil Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pharmaceutical Grade CBD Oil Market Size by Type
  2. 11.1.1 Asia Pharmaceutical Grade CBD Oil Revenue by Type (2021-2032)
  3. 11.1.2 Asia Pharmaceutical Grade CBD Oil Sales by Type (2021-2032)
  4. 11.1.3 Asia Pharmaceutical Grade CBD Oil Price by Type (2021-2032)
  5. 11.2 Asia Pharmaceutical Grade CBD Oil Market Size by Application
  6. 11.2.1 Asia Pharmaceutical Grade CBD Oil Revenue by Application (2021-2032)
  7. 11.2.2 Asia Pharmaceutical Grade CBD Oil Sales by Application (2021-2032)
  8. 11.2.3 Asia Pharmaceutical Grade CBD Oil Price by Application (2021-2032)
  9. 11.3 Asia Pharmaceutical Grade CBD Oil Market Size by Country
  10. 11.3.1 Asia Pharmaceutical Grade CBD Oil Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Pharmaceutical Grade CBD Oil Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Pharmaceutical Grade CBD Oil Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pharmaceutical Grade CBD Oil Market Size by Type
  2. 12.1.1 SAMEA Pharmaceutical Grade CBD Oil Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Pharmaceutical Grade CBD Oil Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Pharmaceutical Grade CBD Oil Price by Type (2021-2032)
  5. 12.2 SAMEA Pharmaceutical Grade CBD Oil Market Size by Application
  6. 12.2.1 SAMEA Pharmaceutical Grade CBD Oil Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Pharmaceutical Grade CBD Oil Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Pharmaceutical Grade CBD Oil Price by Application (2021-2032)
  9. 12.3 SAMEA Pharmaceutical Grade CBD Oil Market Size by Country
  10. 12.3.1 SAMEA Pharmaceutical Grade CBD Oil Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Pharmaceutical Grade CBD Oil Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Pharmaceutical Grade CBD Oil Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Pharmaceutical Grade CBD Oil Value Chain Analysis
  2. 13.1.1 Pharmaceutical Grade CBD Oil Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Pharmaceutical Grade CBD Oil Production Mode & Process
  6. 13.2 Pharmaceutical Grade CBD Oil Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Pharmaceutical Grade CBD Oil Distributors
  9. 13.2.3 Pharmaceutical Grade CBD Oil Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst